Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A hyperaldosteronism subtypes predictive model using ensemble learning.
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T; JPAS/JRAS Study Group. Karashima S, et al. Among authors: ichijo t. Sci Rep. 2023 Feb 21;13(1):3043. doi: 10.1038/s41598-023-29653-2. Sci Rep. 2023. PMID: 36810868 Free PMC article.
Predictor of Steroid Replacement Duration after Removal of Cortisol-producing Adenoma.
Kubo Y, Sone M, Katabami T, Izawa S, Ichijo T, Tsuiki M, Okamura S, Yoshimoto T, Otsuki M, Takeda Y, Suzuki T, Naruse M, Tanabe A; ACPA-J Study Group. Kubo Y, et al. Among authors: ichijo t. Intern Med. 2024 Oct 18. doi: 10.2169/internalmedicine.4339-24. Online ahead of print. Intern Med. 2024. PMID: 39428528 Free article.
Differences in target organ damage between captopril challenge test-defined definitive-positive and borderline-range groups among patients with primary aldosteronism.
Fujiwara N, Haze T, Wakui H, Tamura K, Tsuiki M, Kamemura K, Taura D, Ichijo T, Takahashi Y, Watanabe M, Kobayashi H, Nakamura T, Izawa S, Wada N, Yamada T, Yokota K, Naruse M, Sone M; JPAS II study group. Fujiwara N, et al. Among authors: ichijo t. Hypertens Res. 2024 Oct 15. doi: 10.1038/s41440-024-01943-w. Online ahead of print. Hypertens Res. 2024. PMID: 39402300
Prevalence of unilateral hyperaldosteronism in primary aldosteronism: impact of a novel chemiluminescent immunoassay for measuring plasma aldosterone in Japan.
Kobayashi H, Nakamura Y, Abe M, Nakamura T, Nozato Y, Izawa S, Kakutani M, Katabami T, Wada N, Takahashi K, Yoneda T, Okamoto R, Murakami M, Okamura S, Naruse M, Yokota K, Sone M; JPAS II Study Group. Kobayashi H, et al. Hypertens Res. 2024 Nov;47(11):3035-3044. doi: 10.1038/s41440-024-01786-5. Epub 2024 Jul 29. Hypertens Res. 2024. PMID: 39075322
Assessing Lateralization Index of Adrenal Venous Sampling for Surgical Indication in Primary Aldosteronism.
Kobayashi H, Nakamura Y, Abe M, Ragnarsson O, Gkaniatsa E, Grytaas MA, Løvås K, Wada N, Ichijo T, Heinrich DA, Drake W, O'Toole S, Kocjan T, Kastelan D, Kraljevic I, Yamamoto K, Tsuiki M, Kloock S, Dischinger U, Parasiliti-Caprino M, Sven G, Spyroglou A, Furnica RM, Fallo F, Maiolino G, Kometani M, Wu VC, Beuschlein F, Reincke M, Naruse M. Kobayashi H, et al. Among authors: ichijo t. J Clin Endocrinol Metab. 2024 May 15:dgae336. doi: 10.1210/clinem/dgae336. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38747468
Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation.
Nakano E, Mukai K, Fukuhara A, Otsuki M, Shimomura I, Ichijo T, Tsuiki M, Wada N, Yoneda T, Takeda Y, Oki K, Yamada T, Ogawa Y, Yabe D, Kakutani M, Sone M, Katabami T, Tanabe A, Naruse M; JPAS/JRAS Study Group. Nakano E, et al. Among authors: ichijo t. Endocr J. 2024 May 23;71(5):489-497. doi: 10.1507/endocrj.EJ23-0659. Epub 2024 Mar 14. Endocr J. 2024. PMID: 38479860 Free article.
253 results